Acro Biomedical (ACBM) Change in Receivables (2021 - 2023)
Acro Biomedical (ACBM) posted Change in Receivables of -$18500.0 for Q3 2023, up 83.18% on a QoQ basis from -$110000.0 in Q2 2023, and up 97.01% year-over-year from -$9390.3 in Q3 2022.
Analysis
Acro Biomedical (ACBM) Change in Receivables (2021 - 2023) Analysis & Trends
Acro Biomedical has reported Change in Receivables for 3 years, with the latest figure at -$18500.0 in Q3 2023.
- On a quarterly basis, Change in Receivables rose 97.01% year-over-year to -$18500.0 in Q3 2023; TTM through Jun 2024 was -$18500.0, a 95.36% increase from a year earlier, with the FY2023 full-year figure at -$158500.0, down 491.36% from the prior year.
- Change in Receivables was -$18500.0 for Q3 2023 at Acro Biomedical, up from -$110000.0 in the prior quarter.
- The five-year high for Change in Receivables was $599000.0 in Q2 2022, with the low at -$619000.0 in Q3 2022.
- Average Change in Receivables over 3 years is -$89500.0, with a median of -$70000.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables jumped 160.2% in 2022, then plunged 118.36% in 2023.
- Over 3 years, Change in Receivables stood at -$598000.0 in 2021, then surged by 160.2% to $360000.0 in 2022, then slumped by 105.14% to -$18500.0 in 2023.
- The last three Change in Receivables figures came in at -$18500.0 (Q3 2023), -$110000.0 (Q2 2023), and -$30000.0 (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | 59.00 Mn |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | -28.00 Mn |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | - |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | - |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | 9.80 Mn |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | - |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | 9.40 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -18,500.00 |
| Jun 30, 2023 | -110,000.00 |
| Mar 31, 2023 | -30,000.00 |
| Dec 31, 2022 | 360,000.00 |
| Sep 30, 2022 | -619,000.00 |
| Jun 30, 2022 | 599,000.00 |
| Mar 31, 2022 | -299,500.00 |
| Dec 31, 2021 | -598,000.00 |